Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial

Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases

NCT00242554 ·Status: COMPLETED ·Phase: PHASE4

A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate Cancer

NCT03193060 ·Status: COMPLETED

Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer

NCT00502164 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

NCT04563936 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis

NCT00241111 ·Status: COMPLETED ·Phase: PHASE4

ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)

NCT00090363 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer

NCT00564928 ·Status: COMPLETED ·Phase: PHASE2

A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer

NCT01000948 ·Status: TERMINATED ·Phase: PHASE2

PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients

NCT01020604 ·Status: COMPLETED

Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg

NCT05856630 ·Status: UNKNOWN ·Phase: PHASE1

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.

NCT03971110 ·Status: TERMINATED ·Phase: PHASE4

Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

NCT04295447 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

An Open Label Prostate Cancer Study in Japanese Patients

NCT01351688 ·Status: COMPLETED ·Phase: PHASE1

Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy

NCT00439751 ·Status: COMPLETED ·Phase: PHASE3

Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC

NCT00314782 ·Status: COMPLETED ·Phase: PHASE1

Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer

NCT00226954 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates

NCT00172016 ·Status: COMPLETED ·Phase: PHASE4

Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer

NCT04176081 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

NCT07181161 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms

NCT00005073 ·Status: TERMINATED ·Phase: PHASE3

Casodex/Zoladex Biomarkers in Localised Prostate Cancer

NCT00293696 ·Status: COMPLETED ·Phase: PHASE4

Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

NCT00005044 ·Status: COMPLETED ·Phase: PHASE3

Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer

NCT05003752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer

NCT00414388 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer

NCT00500110 ·Status: COMPLETED ·Phase: PHASE2